Q&A: How Cebranopadol Could Help Address Gaps in Pain Management
Drug Topics
SEPTEMBER 23, 2024
Albert Dahan, MD, PhD, discusses how cebranopadol could fit into the broader landscape of pain management therapies.
Mon.Sep 23, 2024
201 
Startup Particle Health files antitrust lawsuit against Epic alleging it uses monopoly power to block competition
Fierce Healthcare
SEPTEMBER 23, 2024
What began as a dispute between two health tech companies over healthcare data exchange practices has now led to a federal lawsuit alleging antitrust violations. | Venture-backed health tech company Particle Health filed an antitrust lawsuit against Epic in the Southern District of New York alleging that the electronic health records giant is trying to muscle out competition in the payer platform market.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
STAT+: Electronic health records giant Epic Systems sued over alleged monopolistic practices
STAT
SEPTEMBER 23, 2024
The health data company Particle Health has filed an antitrust lawsuit against Epic Systems, alleging that the electronic health record vendor has used its control of patient data to thwart competition and undermine its business. The suit filed Monday in federal court in the Southern District of New York is a full-throated assault on Epic’s dominance in the market for electronic health records, charging that the privately held company has become a “behemoth” and a “mo
FDA Grants Bimekizumab-Bkzx Approval for Treatment of Chronic Immune-Mediated Inflammatory Diseases
Pharmacy Times
SEPTEMBER 23, 2024
Approved with 3 new indications, bimekizumab-bkzx is the first and only interleukin-17 inhibitor approved for these diseases.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT+: A mysterious anti ‘Big Pharma’ bus is barnstorming swing states
STAT
SEPTEMBER 23, 2024
WASHINGTON — The wheels on a big red bus emblazoned with anti-pharmaceutical industry messaging are going ’round and ’round all through the nation’s electoral battlegrounds, from Montana to Arizona to Pennsylvania. But nobody will say who’s paying to fill up the gas tank. A new dark-money group called Americans for Pharma Reform has launched a multi-state bus tour to bring awareness to what they characterize as bad behavior by the pharmaceutical industry.
Favorable Outcomes Possible With IVIG Treatment for Multisystem Inflammatory Syndrome in Children
Pharmacy Times
SEPTEMBER 23, 2024
Further trials are required to examine the long-term feasibility of intravenous immunoglobulin (IVIG) for multisystem inflammatory syndrome.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
PQA to Host Forum on Quality Medication Use in Rare Disease
Pharmacy Times
SEPTEMBER 23, 2024
Event will share patient, specialty pharmacy, pharmaceutical industry and payer perspectives
Opinion: 40 doesn’t look good on Hatch-Waxman
STAT
SEPTEMBER 23, 2024
As the Hatch-Waxman Act approaches its 40th anniversary, it’s time to critically examine its legacy and what it actually gave us: the highest drug prices in the world. One of the main objectives of the Hatch-Waxman Act was to bring more generic drugs into the market. If viewed through that lens only, the act has been an overwhelming success.
UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals
Fierce Pharma
SEPTEMBER 23, 2024
Less than a year after snagging its first FDA approval in psoriasis, UCB’s blockbuster hopeful Bimzelx has picked up three more indications to add to its growing resume of inflammatory disease trea | Along with psoriasis, the biologic is now FDA approved to treat psoriatic arthritis, non-radiographic axial spondyloarthritis and ankylosing spondylitis.
Opinion: New HHS rules can’t address the primary reason for research misconduct
STAT
SEPTEMBER 23, 2024
On Tuesday, the Department of Health and Human Services published new policies on research misconduct , which apply to research institutions receiving funding through the U.S. Public Health Service. The policies set standards that institutions must follow when investigating and potentially sanctioning researchers alleged to have engaged in research misconduct.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Community Pharmacist’s Role in the Management of Migraine
Pharmacy Times
SEPTEMBER 23, 2024
Migraine is a chronic neurological disease characterized by throbbing or pulsating unilateral or bilateral headache that can last from hours to days.
STAT+: Wegovy is among drugs set to be targeted in the next round of Medicare price negotiations, researchers say
STAT
SEPTEMBER 23, 2024
The GLP-1 drug Wegovy tops the list of medications expected to be included in the next round of Medicare price negotiations, according to a paper in the Journal of Managed Care & Specialty Pharmacy. Last month, Medicare officials unveiled prices for the first 10 drugs chosen for negotiation. Now, all eyes are on which Part D drugs will be chosen for the next round of 15 drugs.
J&J hopes 3rd time's the charm for Texas two-step strategy as it lifts talc settlement offer to $8B
Fierce Pharma
SEPTEMBER 23, 2024
Despite being thrown off its rhythm twice already, Johnson & Johnson is making another go of its “Texas two-step” strategy to wash its hands of tens of thousands of lawsuits claiming the compan | Johnson & Johnson is making another go of its “Texas two-step” strategy to wash its hands of tens of thousands of lawsuits claiming the company’s talc products caused users to develop cancer.
STAT+: Risky bet by Biogen and UCB on systemic lupus drug appears to pay off, data show
STAT
SEPTEMBER 23, 2024
Biogen and UCB said Tuesday that an experimental drug reduced disease activity and symptoms of systemic lupus, achieving the primary goal of a placebo-controlled Phase 3 study. Detailed study results were not included in the press release issued by the companies, so how much participants benefited from the drug, called dapirolizumab pegol, won’t be known until data are presented at a medical meeting.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA clears first drug for Niemann-Pick disease
pharmaphorum
SEPTEMBER 23, 2024
Zevra Therapeutics' Miplyffa is first drug approved by the FDA for ultra-rare disease Niemann-Pick type C.
STAT+: As Medicare spending on remote patient monitoring jumps, HHS watchdog warns of fraud, misuse
STAT
SEPTEMBER 23, 2024
The federal watchdog at the Department of Health and Human Services issued a report on Tuesday calling for more oversight of remote patient monitoring in Medicare. The Office of Inspector General’s report called out the potential for fraud and misuse of tools like at-home blood pressure cuffs, connected scales, and continuous glucose monitors that can feed data directly to a patient’s doctor.
FDA Approves Bimekizumab-Bkzx for Psoriatic Arthritis, 2 Other Indications
Drug Topics
SEPTEMBER 23, 2024
The monoclonal antibody was also approved for active non-radiographic axial spondyloarthritis and active ankylosing spondylitis.
Appeals Court resurrects PhRMA's lawsuit challenging pricing provisions in IRA
Fierce Pharma
SEPTEMBER 23, 2024
For trade group the Pharmaceutical Research and Manufacturers of America (PhRMA), the fight against pricing provisions in the Inflation Reduction Act isn’t over yet. | Late last week, the U.S. Court of Appeals for the Fifth Circuit reversed a previous dismissal of PhRMA’s Inflation Reduction Act (IRA) lawsuit from February, punting the complaint back to a lower Texas court.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Accepts NDA for Delgocitinib Cream to Treat Chronic Hand Eczema
Drug Topics
SEPTEMBER 23, 2024
LEO Pharma expects the regulatory review process to be completed in the second half of 2025.
FDA clears RHYTHM AI's new algorithm for atrial fibrillation
pharmaphorum
SEPTEMBER 23, 2024
RHYTHM AI has FDA approval for a new version of its algorithm for mapping areas of the heart that are affected by atrial fibrillation
FDA, CDC: E-Cigarette Use Among Youth Continues to Plummet
Drug Topics
SEPTEMBER 23, 2024
Initiatives such as media campaigns and legislative rulings by the agencies have likely contributed to the decline.
FDA Accepts New Drug Application for Delgocitinib Cream to Treat Chronic Hand Eczema
Pharmacy Times
SEPTEMBER 23, 2024
If approved, delgocitinib cream would be the first US treatment indicated for moderate to severe chronic hand eczema.
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
Pharmaceutical Technology
SEPTEMBER 23, 2024
The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for self-administration.
Legend Biotech inks deal for 'priority access' to Multiply Labs' robotic cell therapy production tech
Fierce Pharma
SEPTEMBER 23, 2024
After several years spent honing its robotic cell therapy manufacturing system, Multiply Labs has snared its first collaboration with a major cell therapy developer. | After several years spent building partnerships to hone its robotic cell therapy manufacturing system, Multiply Labs has snared its first collaboration with a major cell therapy developer: Legend Biotech.
Why UnitedHealthcare is putting a focus on simplicity in its AI strategy
Fierce Healthcare
SEPTEMBER 23, 2024
It's not a secret that navigating the healthcare system is complicated, and the UnitedHealthcare team has rolled out a tool backed by artificial intelligence that aims to make it easier for members | It's not a secret that navigating the healthcare system is complicated, and the UnitedHealthcare team has rolled out a tool backed by artificial intelligence that aims to make it easier for members to shop around.
Monday mysteries: An anti-pharma bus and Missouri bird flu updates
STAT
SEPTEMBER 23, 2024
Good morning! Health care challenges like anti-microbial resistance have long created narrative tension for shows like Grey’s Anatomy. But what about an entire musical about it? Ask and ye shall receive. The wheels on the anti-pharma bus … echo GOP talking points A new, dark money group called Americans for Pharma Reform is aiming to bring awareness to what they call bad behavior by the pharmaceutical industry.
CEEVs, Neurovascular Coupling, and Functional Connectivity Are Potential Markers For Mild Cognitive Impairment
Pharmacy Times
SEPTEMBER 23, 2024
The authors note this is the first study to assess cerebrovascular endothelial extracellular vesicles within a cognitive condition.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics
SEPTEMBER 23, 2024
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Study Finds Measles-Rubella Disease Surveillance System Lacks Networking, Partnerships, and Community Involvement
Pharmacy Times
SEPTEMBER 23, 2024
A 95% increase in private health center participation, monitoring, assessment, and vaccine coverage can be significant in improving outcomes.
Leading Artificial Intelligence (AI) Companies in Pharma
Pharmaceutical Technology
SEPTEMBER 23, 2024
View the top artificial intelligence (AI) companies in the pharmaceutical industry and download your free guide to AI in pharma here.
Warren, others urge government to allow generics to Novo's blockbuster GLP-1s ahead of CEO hearing
Fierce Pharma
SEPTEMBER 23, 2024
Ahead of a Senate hearing centered on high prices for Novo Nordisk’s in-demand semaglutide medications, lawmakers are pressing the government to use its “march-in” rights and allow generic versions | In a letter to HHS secretary Xavier Becerra, several lawmakers urged the government to allow generic licenses for Novo's GLP-1 medicines Ozempic and Wegovy.
Active Pharmaceutical Ingredients and Intermediates for the Pharmaceutical Industry
Pharmaceutical Technology
SEPTEMBER 23, 2024
Download our free, extensive list of the leading Active Pharmaceutical Ingredients and Intermediates companies and suppliers today.
Innovating pharma: How technology can ensure a steady medication supply
pharmaphorum
SEPTEMBER 23, 2024
Innovative pharmaceutical technology can help ensure a consistent medication supply, reducing patient anxiety. Learn more about how advancements in the field are making a difference.
Let's personalize your content